Brian E. Huber

3.6k total citations
63 papers, 2.9k citations indexed

About

Brian E. Huber is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Brian E. Huber has authored 63 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Genetics and 17 papers in Oncology. Recurrent topics in Brian E. Huber's work include Virus-based gene therapy research (15 papers), Cancer Research and Treatments (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Brian E. Huber is often cited by papers focused on Virus-based gene therapy research (15 papers), Cancer Research and Treatments (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Brian E. Huber collaborates with scholars based in United States, Germany and Sweden. Brian E. Huber's co-authors include Elizabeth A. Austin, C A Richards, Steven S. Good, Thomas A. Krenitsky, Cynthia A. Richards, Stephen T. Davis, V C Knick, Peter Kämpfer, Snorri S. Thorgeirsson and E G Lapetina and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Brian E. Huber

62 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian E. Huber United States 24 1.6k 1.2k 711 526 395 63 2.9k
Masaki Kita Japan 32 1.2k 0.7× 306 0.3× 235 0.3× 659 1.3× 183 0.5× 147 3.7k
Nobuo Tsuchida Japan 38 2.9k 1.8× 813 0.7× 1.5k 2.1× 222 0.4× 327 0.8× 119 4.5k
Kazuhiko Yamada Japan 29 913 0.6× 644 0.6× 226 0.3× 99 0.2× 143 0.4× 125 2.7k
Jan Smida Germany 27 1.1k 0.7× 236 0.2× 231 0.3× 105 0.2× 181 0.5× 70 1.8k
Catherine A. Reznikoff United States 28 2.2k 1.4× 549 0.5× 977 1.4× 260 0.5× 257 0.7× 70 4.1k
Joseph A. DiPaolo United States 46 3.4k 2.1× 1.4k 1.2× 1.6k 2.2× 226 0.4× 2.0k 5.1× 229 7.5k
Judith Romero–Gallo United States 37 1.5k 0.9× 268 0.2× 651 0.9× 110 0.2× 236 0.6× 81 4.2k
Roger W. Wiseman United States 46 3.4k 2.1× 1.5k 1.3× 1.9k 2.6× 231 0.4× 547 1.4× 154 7.2k
Hideo Yamagata Japan 37 2.2k 1.4× 999 0.9× 335 0.5× 818 1.6× 126 0.3× 115 3.6k
Hubert Mayer Germany 33 2.0k 1.2× 630 0.5× 229 0.3× 83 0.2× 168 0.4× 117 3.6k

Countries citing papers authored by Brian E. Huber

Since Specialization
Citations

This map shows the geographic impact of Brian E. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Huber more than expected).

Fields of papers citing papers by Brian E. Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian E. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Huber. The network helps show where Brian E. Huber may publish in the future.

Co-authorship network of co-authors of Brian E. Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Brian E. Huber. A scholar is included among the top collaborators of Brian E. Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian E. Huber. Brian E. Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahsen, Nicolas von, Niels Kruse, Brian E. Huber, et al.. (2009). ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain. 132(9). 2517–2530. 55 indexed citations
3.
Kämpfer, Peter, et al.. (2009). Pseudochrobactrum lubricantis sp. nov., isolated from a metal-working fluid. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 59(10). 2464–2467. 12 indexed citations
4.
Fahrbach, Michael, Jan Kuever, Brian E. Huber, et al.. (2008). Steroidobacter denitrificans gen. nov., sp. nov., a steroidal hormone-degrading gammaproteobacterium. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 58(9). 2215–2223. 168 indexed citations
5.
Kämpfer, Peter, et al.. (2008). Ochrobactrum rhizosphaerae sp. nov. and Ochrobactrum thiophenivorans sp. nov., isolated from the environment. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 58(6). 1426–1431. 31 indexed citations
6.
Scholz, Holger C., Zdeněk Hubálek, Ivo Sedláček, et al.. (2008). Brucella microti sp. nov., isolated from the common vole Microtus arvalis. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 58(2). 375–382. 265 indexed citations
7.
Li, Zhuangwu, Naga Shanmugam, Dai Katayose, et al.. (1997). Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.. PubMed. 4(2). 113–7. 41 indexed citations
8.
9.
Richards, Cynthia A., Elizabeth A. Austin, & Brian E. Huber. (1995). Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy. Human Gene Therapy. 6(7). 881–893. 130 indexed citations
10.
Huber, Brian E., et al.. (1994). Characterization of the “hepatic” asialoglycoprotein receptor in rat late-stage spermatids and epididymal sperm. Gene. 148(2). 261–268. 2 indexed citations
11.
Huber, Brian E., et al.. (1994). The major form of the murine asialoglycoprotein receptor: cDNA sequence and expression in liver, testis and epididymis. Gene. 148(2). 237–244. 20 indexed citations
12.
Richards, Cynthia A., Alisa S. Wolberg, & Brian E. Huber. (1993). The transcriptional control region of the human carcinoembryonic antigen gene: DNA sequence and homology studies. DNA sequence. 4(3). 185–196. 9 indexed citations
13.
Huber, Brian E., et al.. (1992). Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene. Molecular Carcinogenesis. 5(4). 293–300. 5 indexed citations
14.
Huber, Brian E.. (1992). Late-stage spermatids are characterized by expression of the "liver-specific" asialoglycoprotein receptor, RHL-1.. Molecular Pharmacology. 41(4). 639–644. 14 indexed citations
15.
Smith, Gary K., Thomas J. Monaco, R. Rigual, et al.. (1990). Activity of an NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase in normal tissue, neoplastic cells, and oncogene-transformed cells. Archives of Biochemistry and Biophysics. 283(2). 367–371. 23 indexed citations
16.
McManaway, Mary E., Bruce Shiramizu, Kishor Bhatia, et al.. (1990). Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. The Lancet. 335(8693). 808–811. 115 indexed citations
17.
Duronio, Vincent, Brian E. Huber, & Steven Jacobs. (1990). Partial down‐regulation of protein kinase C reverses the growth inhibitory effect of phorbol esters on HepG2 cells. Journal of Cellular Physiology. 145(2). 381–389. 42 indexed citations
18.
Garfield, Susan H., Brian E. Huber, Péter Nagy, Michael G. Cordingley, & Snorri S. Thorgeirsson. (1988). Neoplastic transformation and lineage switching of rat liver epithelial cells by retrovirus‐associated oncogenes. Molecular Carcinogenesis. 1(3). 189–195. 40 indexed citations
19.
Huber, Brian E., C A Heilman, Peter J. Wirth, Mark J. Miller, & Snorri S. Thorgeirsson. (1986). Studies of Gene Transcription and Translation in Regenerating Rat Liver. Hepatology. 6(2). 209–219. 23 indexed citations
20.
Dearfield, Kerry L., David Jacobson‐Kram, Brian E. Huber, & Jerry R. Williams. (1986). Induction of sister chromatid exchanges in human and rat hepatoma cell lines by cyclophosphamide and phosphoramide mustard and the effects of cytochrome P-450 inhibitors. Biochemical Pharmacology. 35(13). 2199–2205. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaki Kita Breakdown of academic impact, for papers by Nobuo Tsuchida Breakdown of academic impact, for papers by Kazuhiko Yamada Breakdown of academic impact, for papers by Jan Smida Breakdown of academic impact, for papers by Catherine A. Reznikoff Breakdown of academic impact, for papers by Joseph A. DiPaolo Breakdown of academic impact, for papers by Judith Romero–Gallo Breakdown of academic impact, for papers by Roger W. Wiseman Breakdown of academic impact, for papers by Hideo Yamagata Breakdown of academic impact, for papers by Hubert Mayer
Rankless by CCL
2026